Latest News in the pharma Industry

Top Stories

Bend Research & Xcelience Ink Drug Development Deal

Bend Research & Xcelience Ink Drug Development Deal

25 Aug 2011

The collaboration will combine Bend’s formulation/processing expertise for delivering poorly soluble compounds with Xcelience’s early-phase development expertise.

Read more 
Par Pharmaceutical To Acquire Anchen for $410M

Par Pharmaceutical To Acquire Anchen for $410M

25 Aug 2011

Par Pharmaceutical Companies said it has agreed to acquire privately-held Anchen Pharmaceuticals for $410 million in cash.

Read more 
Study: Majority of Pharma Ads Not Comply with FDA Norms

Study: Majority of Pharma Ads Not Comply with FDA Norms

25 Aug 2011

The study found that of 192 pharmaceutical adverts, only 18% were compliant with the US FDA guidelines.

Read more 
Novo Nordisk to Build New Corporate Centre

Novo Nordisk to Build New Corporate Centre

25 Aug 2011

With the new premises, Novo Nordisk will be consolidating a number of administrative functions currently scattered across Greater Copenhagen.

Read more 
Study Focuses on Drug Delivery Innovations

Study Focuses on Drug Delivery Innovations

25 Aug 2011

A study estimates that needle-free drug delivery methods will have annual revenue growth of 15.1% on average from 2011 to 2016 to reach US$6.2bn.

Read more 
Takeda Receives Subsidy to Develop Influenza Vaccine

Takeda Receives Subsidy to Develop Influenza Vaccine

24 Aug 2011

Takeda will have a JPY23.9bn (US$312m) government subsidy to develop a new influenza vaccine.

Read more 
Par & Intellipharmaceutics Expand ADHD Pact

Par & Intellipharmaceutics Expand ADHD Pact

19 Aug 2011

The two pharma firms have added the development and commercialization of additional strengths of generic Focalin XR for the U.S. market to their existing agreement.

Read more 
Boehringer Ingelheim & ProBioGen Sign Licensing Agreement for Antibody Technology

Boehringer Ingelheim & ProBioGen Sign Licensing Agreement for Antibody Technology

19 Aug 2011

Boehringer Ingelheim will apply ProBioGen's technology to enhance ADCC (Antibody-Dependent Cell-Mediated Cytotoxicity) activity of antibodies.

Read more 
Paladin Labs to Acquire Labopharm

Paladin Labs to Acquire Labopharm

18 Aug 2011

Paladin Labs will purchase drug technology developer Labopharm in a deal valued at over $20.4 million.

Read more 
Roche Relaunches Arthritis Drug in UK

Roche Relaunches Arthritis Drug in UK

18 Aug 2011

Roche's Toclizumab is already licensed to treat adults with severe arthritis, but as of today the drug will be available for children.

Read more 
Survey Reveals Business Concerns of Healthcare Companies

Survey Reveals Business Concerns of Healthcare Companies

18 Aug 2011

According to the survey, changes in healthcare legislation and reform top the list of business concerns of healthcare companies in the US and Asia.

Read more 
Carlyle in Talks to Buy PPD

Carlyle in Talks to Buy PPD

17 Aug 2011

Carlyle Group is in exclusive talks to buy North Carolina-based CRO company Pharmaceutical Product Development.

Read more